A randomized trial of saline hydration to prevent contrast-induced nephropathy in patients on regular captopril or furosemide therapy undergoing percutaneous coronary intervention
Contrast-induced nephropathy (CIN) is characterized by acute deterioration of renal function that occurs after parenteral administration of contrast media in the absence of other causes. Although no definite proof has been obtained yet, the risk of diuretics or angiotensin-converting enzyme inhibito...
Main Authors: | Hassan Shemirani, Masood Pourrmoghaddas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Saudi Journal of Kidney Diseases and Transplantation |
Online Access: | http://www.sjkdt.org/article.asp?issn=1319-2442;year=2012;volume=23;issue=2;spage=280;epage=285;aulast=Shemirani |
Similar Items
-
The Role of Diuretics and Angiotensin-converting enzyme inhibitors on Contrast- Induced Nephropathy in Patients after Percutaneous Coronary Intervention
by: Alireza Dadpey, et al.
Published: (2007-12-01) -
The Effects of Pentoxifylline on Contrast-induced Nephropathy Reduction in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Rouzbahani, et al.
Published: (2022-10-01) -
RISK FACTORS FOR DEVELOPMENT OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
by: Ikram Ullah, et al.
Published: (2017-07-01) -
Contrast induced nephropathy in very elderly patients undergoing percutaneous coronary intervention for acute coronary syndrome
by: Vipin Thomas, et al.
Published: (2017-11-01) -
Captopril for prevention of Contrast Induced Nephropathy in patients undergoing Coronary Angioplasty: A double blind placebo controlled clinical trial
by: M Hashemi, et al.
Published: (2005-09-01)